NEW YORK, Jan. 29 Reportlinker.com announces that a new market research report is available in its catalogue:
Analgesics - A Worldwide Market Intelligence Report
Advertisement
http://www.reportlinker.com/p0164216/Analgesics---A-Worldwide-Market-Intelligence-Report.html
An aging baby boomer population and subsequent rise in geriatric population, and rising therapeutic benefits of pain treatment drugs (internal) are major factors driving growth in the global analgesics market. Expanding number of surgical procedures, and longer life of patients suffering from chronic illnesses such as cancer and AIDS further contribute to increased demand for analgesics. The market is characterized by the presence of a large number of patent-expired products.
Advertisement
Dynamics of the pain management drugs market witnessed significant changes in recent years. The failure of several drugs, considered initially as promisingly curative including recent unsuccessful COX-2 inhibitors, prompted manufacturers and researchers to undertake more research programs. There is a lucrative market for effective analgesics, which do not cause any adverse side effects.
These and other market data and trends are presented in "Analgesics: A Worldwide Market Intelligence Report" by BizAcumen, Inc. Our reports are designed to be most comprehensive in geographic coverage and vertical market analyses.
ANALGESICS BMR-1016
CONTENTS
1. METHODOLOGY 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Quantitative Techniques & Reporting Level 3
2. GLOBAL ANALGESICS MARKET OVERVIEW 4
Pain Therapeutic Market 4
Analgesics Market - Offering Immense Potential 4
Liquid Analgesics Register Rapid Growth 4
Neuropathic Pain - Unexplored 5
Ibuprofen Scoring High 5
External Analgesics - In a slump 5
Boom in Demand for Topical Analgesic Patches 5
3. PRODUCT FACTS 6
1. Internal Analgesics 6
Aspirin 6
Acetaminophen 6
Ibuprofen 6
Others (includes combination drugs) 6
2. External Analgesics 6
Combination Analgesics 6
4. MARKET TRENDS 7
Escalating R&D Costs: A Boon or Bane? 7
Cox II Crisis Tarnishes Industry Growth 7
Novel Therapies to Propel Opioid and Non-Opioid Therapies 8
Rx-to-OTC Switch 8
Why Consumers Prefer OTC Drugs? 8
Development of Analgesic Tripeptides 9
5. CORPORATE DEVELOPMENTS 9
Bayer to Acquire Sagmel's OTC Business 9
E5 Pharma Receives Approval from FDA 9
Pharmaceutical Associates Receives Approval from FDA 9
Concord Receives New Drug Approvals 9
Hisamitsu Receives Approval for SALONPAsO 9
Johnson & Johnson Submits NDA to FDA 10
Nycomed and Paladin Inks Joint-Promotion Agreement for Tridural 10
Akela Extends Agreement with Janssen 10
Daiichi and Lead Chemical Receives Approval for LoxoninO Tape 10
Tokio Marine Capital to Acquire Showa Yakuhin Kako 11
Corgenix Collaborates with Randox Laboratories 11
Corgenix Receives EPO Approval for Aspirin Resistance Method 11
IOL to Expand Production Capacity 11
American Oriental Bioengineering Partners with China Aoxing 11
Abraxis Takes Over Shimoda and its Subsidiary Company 11
ProEthic Pharmaceuticals Releases Ibudone for Acute Pain
Management 12
Dr. Reddy's Laboratories Introduces Supanac for Acute Pain
Management 12
PLx Initiates Clinical Trial For Aspirin-PC 12
Ranbaxy Receives Approval from FDA 12
Wockhardt Receives FDA Approval for DPN + APAP 12
Alpharma to Market Flector® Patch in the US 13
Auriga and Mikart Inks Agreement to Market Codein 13
Watson Receives FDA Approval for Oxycodone Hydrochloride and
Ibuprofen 13
Labopharm's Tramadol Receives Approval in Canada 13
Lion Acquires BUFFERIN® Trademark Rights 13
Grunenthal's Extends Licensing Agreement with Ortho-McNeil 14
China Aoxing Pockets LRT 14
Anesiva Inks Joint Venture Agreement Wanbang 14
Beijing Med-Pharm Inks Agreement with Lotus Healthcare 14
LAB International Inks Licensing Agreement with Janssen
Pharmaceutica 14
Three Sixty Pockets Rockford-Montgomery Labs 15
Antares Enters into License and Development Agreement for
Opioid Analgesic 15
Neurodiscovery Receives Approval for NSL-101 Phase II
Clinical Trials 15
Mallinckrodt Introduces Magnacet(TM) Tablets for Pain Management 15
Wockhardt to Launch New Painkiller 15
Paladin Labs and Labopharm Introduce Tridural(TM) 15
Shionogi & Co Introduces OxiNorm Powder 0.5% 16
6. MAJOR PLAYERS 16
Bayer Consumer Care (USA) 16
Bristol-Myers Squibb Company (USA) 16
Johnson & Johnson (USA) 16
McNeil Consumer Healthcare (Canada) 17
Novartis International AG (Switzerland) 17
Pfizer Inc. (USA) 17
Reckitt Benckiser Group Plc (UK) 17
Sanofi Aventis (France) 18
Wyeth (USA) 18
Wyeth Consumer Healthcare 18
7. MARKET ANALYTICS 19
8. THE UNITED STATES 27
Pain Statistics in the US 27
Industry Overview 27
Internal Analgesics 28
Cox-2 Drugs in for Some Trouble 28
Switch to OTC Drugs 28
Promotional Strategies for the Internal Analgesics 30
Pediatric Analgesics: The New Kid on the Block 30
External Analgesics 30
Stretching Boundaries 30
Rubs, Patches: Driving the External Analgesics Market 31
Patch Relief Gaining Momentum 32
9. CANADA 33
10. JAPAN 34
11. EUROPE 35
European Pain Management Market 36
Generics Restrain Revenue Growth 36
a. France 39
b. Germany 41
c. The United Kingdom 43
d. Italy 44
e. Spain 46
f. Rest of Europe 48
12. ASIA-PACIFIC 49
The OTC Analgesic Market 49
Comparison of Major Regions for OTC Analgesics Market in
Asia-Pacific - 2004 49
Aspirin - The Chinese Market 49
13. LATIN AMERICA 51
14. REST OF WORLD 52
EXHIBITS
Table 1: Market Shares of Opioid/ Acetaminophen Combination
Products in the Opioid Script Volume
Table 2: Global Analgesics Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 3: Percentage Breakdown of Global Analgesics Market by
Region for the Years 2008 & 2012
Table 4: Global Internal Analgesics Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 5: Percentage Breakdown of Global Internal Analgesics
Market by Region for the Years 2008 & 2012
Table 6: Global Internal Analgesics Market by Segment for the
Period 2007-2015 (Sales in US$ Million)
Table 7: Percentage Breakdown of Global Internal Analgesics
Market by Segment for the Years 2008 & 2012
Table 8: Global Aspirin Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 9: Percentage Breakdown of Global Aspirin Market by
Region for the Years 2008 & 2012
Table 10: Global Acetaminophen Market by Region for the
Period 2007-2015 (Sales in US$ Million)
Table 11: Percentage Breakdown of Global Acetaminophen Market
by Region for the Years 2008 & 2012
Table 12: Global Ibuprofen Market by Region for the Period
2007-2015 (Sales in US$ Million)
Table 13: Percentage Breakdown of Global Ibuprofen Market by
Region for the Years 2008 & 2012
Table 14: Global Other Internal Analgesics Market by Region
for the Period 2007-2015 (Sales in US$ Million)
Table 15: Percentage Breakdown of Global Other Internal
Analgesics Market by Region for the Years 2008 & 2012
Table 16: Global External Analgesics by Region for the Period
2007-2015 (Sales in US$ Million)
Table 17: Percentage Breakdown of Global External Analgesics
by Region for the Years 2008 & 2012
Table 18: Market Shares of Top Ten Brands in the US Internal
Tablet Analgesics Market - 2007
Table 19: Market Shares of Top Ten Brands in the US Internal
Liquid Analgesics Market - 2007
Table 20: Market Shares of Retail Distribution Channels for
Internal Analgesics in the US - 2008E
Table 21: Market Shares of Retail Distribution Channels for
Internal Liquid Analgesics in the US - 2008E
Table 22: Market Shares of Top Ten Brands in the US External
Analgesics Market - 2007
Table 23: Market Shares of Retail Distribution Channels for
External Analgesics in the US - 2008E
Table 24: Analgesics Market by Segment in US: 2007-2015 (Sales
in US$ Million)
Table 25: Percentage Breakdown of Analgesics Market by Segment
in US for the Years 2008 & 2012
Table 26: Analgesics Market by Segment in Canada: 2007-2015
(Sales in US$ Million)
Table 27: Percentage Breakdown of Analgesics Market by Segment
in Canada for the Years 2008 & 2012
Table 28: Market Shares of Leading OTC Analgesics
Manufacturers in Japan - 2005
Table 29: Analgesics Market by Segment in Japan: 2007-2015
(Sales in US$ Million)
Table 30: Percentage Breakdown of Analgesics Market by Segment
in Japan for the Years 2008 & 2012
Table 31: Market Shares of Popular Brands in the European
Pain & Inflammation Medication Market - 2004
Table 32: Analgesics Market by Region in Europe: 2007-2015
(Sales in US$ Million)
Table 33: Percentage Breakdown of Analgesics Market by Region
in Europe for the Years 2008 & 2012
Table 34: Analgesics Market by Segment in Europe: 2007-2015
(Sales in US$ Million)
Table 35: Percentage Breakdown of Analgesics Market by Segment
in Europe for the Years 2008 & 2012
Table 36: Market Shares of Leading Analgesics Manufacturers in
France - 2005
Table 37: Analgesics Market by Segment in France: 2007-2015
(Sales in US$ Million)
Table 38: Percentage Breakdown of Analgesics Market by Segment
in France for the Years 2008 & 2012
Table 39: Market Shares of Leading Analgesics Manufacturers in
Germany - 2005
Table 40: Analgesics Market by Segment in Germany: 2007-2015
(Sales in US$ Million)
Table 41: Percentage Breakdown of Analgesics Market by Segment
in Germany for the Years 2008 & 2012
Table 42: Market Shares of Leading Analgesics Manufacturers in
the UK - 2005
Table 43: Analgesics Market by Segment in UK: 2007-2015 (Sales
in US$ Million)
Table 44: Percentage Breakdown of Analgesics Market by Segment
in UK for the Years 2008 & 2012
Table 45: Market Shares of Leading Analgesics Manufacturers in
Italy - 2005
Table 46: Analgesics Market by Segment in Italy: 2007-2015
(Sales in US$ Million)
Table 47: Percentage Breakdown of Analgesics Market by Segment
in Italy for the Years 2008 & 2012
Table 48: Market Shares of Leading Analgesics Manufacturers in
Spain - 2005
Table 49: Analgesics Market by Segment in Spain: 2007-2015
(Sales in US$ Million)
Table 50: Percentage Breakdown of Analgesics Market by Segment
in Spain for the Years 2008 & 2012
Table 51: Analgesics Market by Segment in Rest of Europe:
2007-2015 (Sales in US$ Million)
Table 52: Percentage Breakdown of Analgesics Market by Segment
in Rest of Europe for the Years 2008 & 2012
Table 53: Analgesics Market by Segment in Asia-Pacific:
2007-2015 (Sales in US$ Million)
Table 54: Percentage Breakdown of Analgesics Market by Segment
in Asia- Pacific for the Years 2008 & 2012
Table 55: Analgesics Market by Segment in Latin America:
2007-2015 (Sales in US$ Million)
Table 56: Percentage Breakdown of Analgesics Market by Segment
in Latin America for the Years 2008 & 2012
Table 57: Analgesics Market by Segment in Rest of World:
2007-2015 (Sales in US$ Million)
Table 58: Percentage Breakdown of Analgesics Market by Segment
in Rest of World for the Years 2008 & 2012
COMPANIES PROFILED
To order this report:
: Analgesics - A Worldwide Market Intelligence Report
More Market Research Report
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg Reportlinker Email: nbo@reportlinker.com US: (805)652-2626 Intl: +1 805-652-2626
SOURCE Reportlinker